Sage Group is attending BioEurope virtually Nov 2-4 and will be pleased to meet you! Please click here to setup a call with us or book on the Partnering sessions!

London, England, Shanghai, China, and New York, February 17 2020 - The Sage Group, Inc. today announced that they have partnered with T-Capital to extend their global reach into the People’s Republic of China. The principal objective is to broaden their portfolio of strategic licensing and partnering services for their healthcare clients in pharmaceuticals, diagnostics and medical technology. This will build on a growing transaction volume of their clients in USA and Europe e

SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)-- OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, following shareholder approval, the proposed strategic investment by and partnership (the “CGP/Sirtex Transaction”) with Grand Decade Developments Limited, a wholly owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited (“CGP”), and its U.S. af

London, England and New York, February 5 2020 - The Sage Group, Inc. today announced that Dr. Clarissa Ceruti will join the firm as an Executive Director. “We are very pleased that Clarissa has decided to join Sage. She will significantly expand our capability and expertise in serving the strategic transactional needs of our clients. Also, since Clarissa resides in both Italy and California, Sage will be able to be even more responsive to our clients on the west coast of USA